Literature DB >> 9485432

Time and pH dependence of the L-to-M transition in the photocycle of bacteriorhodopsin and its correlation with proton release.

T Althaus1, M Stockburger.   

Abstract

The pH dependence of the L-to-M transition in the photocycle of bacteriorhodopsin was studied in pump-probe resonance Raman (RR) flow experiments in the range pH 3.5-7.8 on a time scale of 0-700 micros. For pH < 5, following the initial decay of L to M, the two intermediates approach nearly constant levels. From a specially designed perturbation-relaxation experiment at pH 4.6, in which the composition of L and M is perturbed by photoreversal of M, it could be concluded that the incomplete decay of L is due to an intermediate equilibration between L and M. It was found, by both RR and optical transient spectroscopy, that the maximum level of M (approximately 500 micros) increases with pH according to a pKa of 5. 6 (150 mM Na+). Since the proton release from an internal group XH to the extracellular surface is determined by nearly the same pKa of 5.7 [Zimanyi, L., Varo, G., Chang, M., Ni, B., Needleman, R., and Lanyi, J. K. (1992) Biochemistry 31, 8535-8543], it is concluded that this increase is controlled by the dissociation of XH. From the analysis of the perturbation-relaxation experiments and the multiexponential rise of M, a kinetic scheme with two sequential L-M equilibria is proposed for the L-M transition. By comparison with the time behavior of proton release [Heberle, J., and Dencher, N. A. (1992) Proc. Natl. Acad. Sci. U.S.A. 89, 5996-6000], it is suggested that it is the second equilibrium which is further shifted toward the M state by the dissociation of XH. From the magnitude of this shift, it is concluded that the L-M transition and proton release are not as strongly coupled as is generally assumed. Instead, it is proposed that structural changes during the photocycle are the dominating factors which reduce the pKa of XH to approximately 5.7 so that proton release becomes possible under normal conditions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9485432     DOI: 10.1021/bi9714969

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Fourier transform infrared evidence for early deprotonation of Asp(85) at alkaline pH in the photocycle of bacteriorhodopsin mutants containing E194Q.

Authors:  T Lazarova; C Sanz; E Querol; E Padrós
Journal:  Biophys J       Date:  2000-04       Impact factor: 4.033

2.  On the protein residues that control the yield and kinetics of O(630) in the photocycle of bacteriorhodopsin.

Authors:  Q Li; S Bressler; D Ovrutsky; M Ottolenghi; N Friedman; M Sheves
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

3.  Time-resolved step-scan Fourier transform infrared spectroscopy reveals differences between early and late M intermediates of bacteriorhodopsin.

Authors:  C Rödig; I Chizhov; O Weidlich; F Siebert
Journal:  Biophys J       Date:  1999-05       Impact factor: 4.033

4.  Pressure dependence of the photocycle kinetics of bacteriorhodopsin.

Authors:  B U Klink; R Winter; M Engelhard; I Chizhov
Journal:  Biophys J       Date:  2002-12       Impact factor: 4.033

Review 5.  Mitochondrial light switches: optogenetic approaches to control metabolism.

Authors:  Brandon J Berry; Andrew P Wojtovich
Journal:  FEBS J       Date:  2020-06-07       Impact factor: 5.542

6.  Conformational changes of bacteriorhodopsin along the proton-conduction chain as studied with (13)C NMR of [3-(13)C]Ala-labeled protein: arg(82) may function as an information mediator.

Authors:  M Tanio; S Tuzi; S Yamaguchi; R Kawaminami; A Naito; R Needleman; J K Lanyi; H Saitô
Journal:  Biophys J       Date:  1999-09       Impact factor: 4.033

7.  Connectivity of the retinal Schiff base to Asp85 and Asp96 during the bacteriorhodopsin photocycle: the local-access model.

Authors:  L S Brown; A K Dioumaev; R Needleman; J K Lanyi
Journal:  Biophys J       Date:  1998-09       Impact factor: 4.033

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.